Nanogen Announces $7.7 Million Common Stock Sale - News Item

Nanogen, Inc. announced today that it has sold 900,000 shares of its common stock to institutional investors at a price of $8.60 per share, for gross proceeds of approximately $7.7 million. After deducting fees and expenses, Nanogen will receive approximately $7.4 million from the sale, which was conducted pursuant to Nanogen's shelf registration statement filed in January 2004 and increased by 150,000 shares on April 6, 2004.

The sale is expected to close today.

Nanogen plans to use the net proceeds for working capital and other general corporate purposes, including funding of acquired businesses and technologies. Seven Hills Partners LLC acted as exclusive placement agent to Nanogen for this financing.

"This sale completes the placement of shares registered under our shelf registration statement and provides further support for our long-term strategy to commercialize advanced medical diagnostics and to facilitate Nanogen's entry into complementary, high-growth markets," said Howard C. Birndorf, chairman and CEO of Nanogen.

Posted 7th April 2004

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Nanogen. (2013, June 11). Nanogen Announces $7.7 Million Common Stock Sale - News Item. AZoNano. Retrieved on April 17, 2024 from https://www.azonano.com/article.aspx?ArticleID=742.

  • MLA

    Nanogen. "Nanogen Announces $7.7 Million Common Stock Sale - News Item". AZoNano. 17 April 2024. <https://www.azonano.com/article.aspx?ArticleID=742>.

  • Chicago

    Nanogen. "Nanogen Announces $7.7 Million Common Stock Sale - News Item". AZoNano. https://www.azonano.com/article.aspx?ArticleID=742. (accessed April 17, 2024).

  • Harvard

    Nanogen. 2013. Nanogen Announces $7.7 Million Common Stock Sale - News Item. AZoNano, viewed 17 April 2024, https://www.azonano.com/article.aspx?ArticleID=742.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this article?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.